Most Read News

Deccan Gold Mines announced that GMSI informed that a pilot process plant for producing gravity gold concentrates has been commissioned at their key Jonnagiri Gold Project in Andhra Pradesh This Plant will be producing gravity gold concentrates from the gold ore that is being mined from the open pit at Jonnagiri ML area which is already in operation The Company is in the process of […]

Bajaj Finance has allotted 1805 Secured redeemable non-convertibles debentures of face value of Rs 10 lakh each aggregating Rs 18050 crore on private placement basis on 30 December 2021

Sudarshan Chemical Industries announced that CRISIL has reaffirmed its CRISIL A1 pronounced as CRISIL A one plus rating rating to the Rs 50 crore Commercial Paper Programme of the Company

Trident has issued commercial paper aggregating Rs 50 crore on 30 December 2021

The equity shares of Brandbucket Media Technology Scrip Code 543439 are listed and admitted to dealings on the Exchange in the list of MT Group Securities

Mahindra Holidays Resorts India will hold a meeting of the Board of Directors of the Company on 3 February 2022

The Board of TCNS Clothing Co at its meeting held on 30 December 2021 has approved the appointment of Suresh Jayaraman DIN 03033110 as Additional and Independent Non-Executive Director and Arvinder Singh Pasricha DIN 00032420 as Additional and Non-Executive Director subject to the approval of shareholders

United Spirits has received revision in credit ratings from CRISIL as under Total bank loan facilities – Rs 2800 crore Long term rating – CRISIL AAA Stable upgraded from CRISIL AA Positive Short term rating – CRISIL A1 reaffirmed Rs 750 crore Non convertible debentures – Withdrawn Rs 500 crore commercial paper – CRISIL A1 withdrawn

Arex Industries will hold a meeting of the Board of Directors of the Company on 7 January 2022

Zydus Cadilas US subsidiary Zydus Pharmaceuticals USA Inc has received tentative approval from the USFDA to market Pimavanserin Capsules in the strength of 34 mg USRLD Nuplazid Capsules Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis The drug will be manufactured at the groups formulation manufacturing facility at SEZ Ahmedabad The group now […]